Maintenance therapy in schizophrenia: a critical comment.

Area of Science:

• Psychiatry
• Pharmacology
• Clinical Research

Background:

• The established practice of continuous maintenance therapy for schizophrenia is widely used.
• However, the scientific rationale and evidence supporting its efficacy are debated.
• Current treatment strategies may require re-evaluation, especially with the advent of atypical antipsychotics.

Purpose of the Study:

• To evaluate the rationale for maintenance therapy in schizophrenia.
• To explore the feasibility of intermittent targeted therapy as an alternative treatment approach.
• To critically assess current evidence and identify gaps in schizophrenia treatment research.

Main Methods:

• A selective review of English-language literature was conducted.
• Searches were performed using Medline and cross-referencing.
• Literature published since 1966 was included for analysis.

Main Results:

• Evidence supporting continuous maintenance therapy in schizophrenia was found to be equivocal.
• Clinical trials often grouped heterogeneous patient populations, creating a disconnect with clinical practice.
• The definition of relapse in existing studies was frequently narrow, potentially biasing results.

Conclusions:

• The rationale for and optimal duration of maintenance antipsychotic pharmacotherapy in schizophrenia are not adequately validated.
• Intermittent targeted treatment may be a feasible and effective option in specific clinical scenarios.
• Further research is needed to reconsider construct validity of outcome indicators and explore intermittent treatment strategies.